AN INNOVATIVE PREP RESEARCH STUDY FOR WOMEN

HPTN 084 (LIFE) is a research study that compares the effectiveness of injections and oral tablets as pre-exposure prophylaxis (PrEP) to prevent HIV in women.

HPTN 084 will enroll participants in 20 sites in 7 countries in sub-Saharan Africa: Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda and Zimbabwe.

See site contact information here.

The HPTN

HPTN - HIV Prevention Trials Network

HPTN 084 is a study that is part of the NIH-DAIDS-funded HIV Prevention Trials Network (HPTN). Learn more under Additional Information.
<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-109684911-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-109684911-1'); </script> <!-- Hotjar Tracking Code for https://084life.org/ --> <script> (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:704812,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); </script>